Sign up
Quantellect · Congress · Issuer Profile
NASDAQ: ARGXargenx NV ADR
HealthcareMkt Cap $60.37BCongress ownership rank #2204

argenx NV ADR Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 5 trades in argenx NV ADR (NASDAQ: ARGX) since 2023, across 3 members, worth an estimated $64.50K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 4 buys against 1 sell, a modestly buy-led skew, with Democratic members responsible for 80% of the trades and Republican members 20%. The most recent disclosure shown was filed November 2026, and Gilbert Cisneros has filed the most ARGX transactions among those shown, with 3. Other recent filers include Alan Armstrong. One notable disclosed move was a purchase by Alan Armstrong on March 30, 2026, up 33.6% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. argenx NV ADR's current Quantellect Tide Score is 55 out of 100 (High Tide), Top 36% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the argenx NV ADR (ARGX) stock overview and the complete trade table below.

Data updated

Trades
4
Politicians
2
Filings
2
Disclosed Vol
$56.50K
Buys
4
100%
Sells
0
0%

Price & congressional trade timeline

Party breakdown

argenx NV ADR congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Nov 10, 2026Oct 27, 202614 daysBuy
$1,001 - $15,000
+6.66%Self
Nov 10, 2026Oct 15, 202626 daysBuy
$1,001 - $15,000
+11.22%Self
Nov 10, 2026Oct 14, 202627 daysBuy
$15,001 - $50,000
+15.03%Self
Jul 21, 2026Mar 30, 2026113 daysBuy
$1,001 - $15,000
+33.64%Self
Go to

argenx NV ADR (ARGX) congressional trading FAQ

Can members of Congress legally trade argenx NV ADR (ARGX) stock?

Yes. Members of Congress are permitted to trade individual stocks, including argenx NV ADR (ARGX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional argenx NV ADR (ARGX) trades public?

Yes. Every congressional trade in argenx NV ADR (ARGX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded argenx NV ADR (ARGX)?

Members of Congress have disclosed 5 trades in argenx NV ADR (ARGX) worth $64.50K across 3 members, according to public STOCK Act filings.

Which members of Congress have traded argenx NV ADR (ARGX)?

Recent and active filers of argenx NV ADR (ARGX) disclosures include Gilbert Cisneros, Alan Armstrong. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade argenx NV ADR (ARGX) more?

Across disclosed argenx NV ADR (ARGX) trades, 80% were by Democrats and 20% by Republicans, led by Democrats (80%).

What is the most recent congressional argenx NV ADR (ARGX) trade?

The most recent disclosed argenx NV ADR (ARGX) filing reported a buy by Gilbert Cisneros, filed Nov 9, 2026.

What is argenx NV ADR (ARGX)'s Tide Score?

argenx NV ADR (ARGX) has a Quantellect Tide Score of 55 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewargenx NV ADR (ARGX) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.